Gen AI’s real opportunity in drug development? As a smart, strategic decision aid

CSO Ben Sidders speaks with the Journal for Clinical Studies

Biorelate Ltd. CEO and Founder Daniel Jamieson is interviewed alongside other leading pharma thinkers in the PharmaTimes Media Ltd front cover story on reflections and prediction in Pharma

In a fascinating episode of the "Life Science Success" podcast, Dr. Ben Sidders, Chief Science Officer at Biorelate, takes center stage. Host Don Davis, PhD, and MBA, engages in an enlightening conversation with Ben, who shares his journey, insights, and the groundbreaking innovations at Biorelate that promise to reshape the life sciences industry.